SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Veoneer, Inc. (VNE) .
Criteria proven by this page:
- VALUE (10/100, Fail) — analyst consensus target implies downside from the current price ($25.10, 32.1%).
- Analyst consensus target $25.10 (-32.1% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 20/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VNE
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.49
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.45
Book Value / Share$0.00
Revenue / Share$14.85
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$25.10 (-32.1%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.34 |
$1.59B |
$-30M |
-1.9% |
| 2016 |
$-0.61 |
$2.22B |
$-53M |
-2.4% |
| 2017 |
$-2.49 |
$2.32B |
$-217M |
-9.3% |
| 2018 |
$-3.17 |
$2.23B |
$-276M |
-12.4% |
| 2019 |
$-4.92 |
$1.9B |
$-500M |
-26.3% |
| 2020 |
$-4.88 |
$1.37B |
$-544M |
-39.6% |
| 2021 |
$-3.45 |
$1.66B |
$-385M |
-23.2% |
